OpenVSafe by OpenVAERS
Search V-safe

YA7-12587-14386

3 vaccinations 7 coded responses 39 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
024 / MA
Registered
2021-04-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
TRZ-32583-98418 Child or adolescent in my care · Male · 2021-11-04
PNL-95549-94421 Child or adolescent in my care · Female · 2021-11-04

Timeline

  1. 2021-04-19
    Registered in v-safe
  2. 2021-04-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-19
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-26
    Health check-in — day 7, dose 1
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  11. 2021-05-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-10
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-10
    Survey response — day 0, dose 2
    MedDRA: Lip swelling, Rash, Vaccine positive rechallenge — Feeling: Good · Site: Pain
    Free text: Facial rash and lip swelling persist since 1st injection; not new today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cheilitis, Rash — Feeling: Good · Site: Pain
    Free text: Face/lip rash persist since first dose; not new since 2nd dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Still have facial rash from after 1st injection; not new after 2nd
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-05-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Facial rash persists from 1st shot; not new since 2nd shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Facial rash since 1st shot persists; not new since 2nd shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Facial rash persists since 1st shot; not new since 2nd shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-09
    Survey response — 3 months, dose 2
    MedDRA: Cough, SARS-CoV-2 test negative — Feeling: Good
    Free text: Coughing for ~10 days. Had a negative covid test and no known exposure. Coughing has resolved.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-11-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-24
    Dose 3 — Pfizer-BioNTech
  29. 2021-11-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  30. 2021-11-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, Abdominal pain
    Adult check-in
  31. 2021-11-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  32. 2021-11-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-12-01
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-12-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-15
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-29
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-02-24
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-05-25
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-11-24
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-19Pfizer-BioNTech
22021-05-10Pfizer-BioNTech
32021-11-24Pfizer-BioNTech No

Free text

Release 8 — day 0, dose 2

2021-05-10

Systemic reaction (other): Facial rash and lip swelling persist since 1st injection; not new today

Release 8 — days 1–6 daily, dose 2

2021-05-11

Systemic reaction (other): Face/lip rash persist since first dose; not new since 2nd dose

2021-05-12

Systemic reaction (other): Still have facial rash from after 1st injection; not new after 2nd

2021-05-13

Systemic reaction (other): Facial rash persists from 1st shot; not new since 2nd shot

2021-05-14

Systemic reaction (other): Facial rash since 1st shot persists; not new since 2nd shot

2021-05-15

Systemic reaction (other): Facial rash persists since 1st shot; not new since 2nd shot

Release 9 — 3 months, dose 2

2021-08-09

Symptoms: Coughing for ~10 days. Had a negative covid test and no known exposure. Coughing has resolved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ · ✓
SDSARS-CoV-2 test negative ✓ · ✓
SROCheilitis ✓ ✓ ✓
SROLip swelling ✓ ✓ ✓
SRORash ✓ ✓ ✓
SROVaccine positive rechallenge ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release